Drug Testing Locations - Point, LA

Drug Testing in Point, LA

Point, Louisiana Statistics

In 2022, Point residents of Vermilion Parish experienced a 15% rise in opioid-related overdoses.

Point in Vermilion Parish saw 25 heroin-related arrests in 2022.

Methamphetamine use increased by 20% among young adults in Vermilion Parish in 2021.

In 2021, Point's Vermilion Parish reported a 10% decline in prescription drug abuse.

Vermilion Parish recorded 50 drug trafficking cases in Point during 2022.

Alcohol-related emergency room visits in Point, Vermilion Parish, rose by 18% in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Point, LA & Drug Testing Policies

Employers in Point, LA, have heightened their drug testing policies to ensure a safe and productive work environment. Many local businesses adhere to the guidelines set by the Occupational Safety and Health Administration which emphasize the importance of maintaining a drug-free workplace. Regular testing is conducted, with some employers opting for random tests.

Companies collaborate with testing facilities and use advanced testing methods to detect various substances. Ensuring compliance with local and federal laws, employers in Vermilion Parish prioritize employee health and safety, and support those seeking rehabilitation through comprehensive assistance programs.

Government Efforts with Drug Problems in Point, LA

In Point, LA, located in Vermilion Parish, the government is actively working to combat drug abuse through various initiatives. The Substance Abuse and Mental Health Services Administration and local agencies provide resources and support for prevention and treatment programs. Collaborative efforts focus on educating the community and reducing the stigma of addiction.

Efforts are also supported by the Louisiana Department of Health by funding local treatment centers and educational programs. Law enforcement agencies, such as the Vermilion Parish Sheriff's Office, implement drug prevention strategies and conduct awareness campaigns, aiming to reduce drug supply and demand locally.

Local Drug Busts & News in Point, LA

In recent years, Point in Vermilion Parish has experienced several significant drug-related events. Law enforcement agencies collaborated in a major operation in 2022, resulting in the dismantling of a large drug trafficking ring, seizing various illegal substances and weapons.

Local community meetings and events have been held to raise awareness about the ongoing drug issues, with participation from various stakeholders, including law enforcement, health professionals, and residents. These events aim to promote community awareness and encourage a joint effort in battling the drug crisis.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Point, LA. Trusted by employers nationwide for accurate results and exceptional service.

Louisiana DOT/Non DOT Physicals

Louisiana Vision Tests

Louisiana Audiograms

Louisiana Respirator Fit Tests

Louisiana Lift Tests

Louisiana Background Checks

Clinical Testing Services

TB Testing in LA

Diabetes Testing in LA

Infectious Disease Testing in LA

Sickle Cell Anemia Testing in LA

Women/Men's Health Testing in LA

Resources & Citations

Addiction Resource

Louisiana Department of Health

SAMHSA

NIDA

RehabCenter.net

NCADD

Louisiana Drug Rehab Centers

The Wood Group

Harmony Treatment

Northshore Openings

Drug Testing Near Point, LA

Swartz, LA

Lakeshore, LA

Sicard, LA

Choudrant, LA

Indian Village, LA

Bawcomville, LA

Brownsville-Bawcomville, LA

Fairbanks, LA

Haile, LA

Brownsville, LA

West Monroe, LA

Sterlington, LA

Farmerville, LA

Spencer, LA

Downsville, LA

Frequently Asked Questions

Customer Reviews